This document reports on a case of primary malignant melanoma of the vagina identified through cytological examination. A 74-year-old woman presented with a prolapsed anterior vaginal wall and exophytic lesions. A direct smear showed malignant cells that were initially misdiagnosed as squamous cell carcinoma. Biopsy revealed the presence of melanin pigment indicating malignant melanoma. Primary melanoma of the vagina is rare, accounting for less than 3% of vaginal malignancies. Accurate cytological diagnosis is challenging due to the rarity of this cancer and lack of overt pigmentation in some cases.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
A malignant neoplasm that contains elements of carcinoma (cancer of epithelial tissue, which is skin and tissue that lines or covers the internal organs) and sarcoma (cancer of connective tissue, such as bone, cartilage, and fat) so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
A malignant neoplasm that contains elements of carcinoma (cancer of epithelial tissue, which is skin and tissue that lines or covers the internal organs) and sarcoma (cancer of connective tissue, such as bone, cartilage, and fat) so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Linitis plastica is a diffuse form of gastric cancer and accounts for about 10% of all cases of gastric malignancy and its exact general population distribution is unknown. There are no characteristic or specific symptoms, the symptoms are similar to those of other forms of stomach cancer and can manifest as a feeling of fullness after eating, nausea and vomiting, epigastric pain, weight loss, and progressive dysphagia [1]. Plastic linitisis characterized by malignant glandular proliferation of cricoid cells in the fibrous stroma, which ultimately leads to thickening and rigidity of the stomach wall.
Objective: To analyze the sonographic features of different histopathological subtypes of borderline ovarian tumors (BOTs) confirmed by pathology, and to study the ultrasound performances of various types in borderline ovarian tumors.
Study Design: Retrospective analysis was performed on the pathological results and ultrasound projection findings of 129 patients diagnosed as BOTs by ultrasound department of our hospital from January 2012 to November 2019. All patients were confirmed by surgical pathology and scanned consecutively by the investigators using transabdominal or transvaginal ultrasound examination.
Results: Serous borderline tumors (SBOTs) were observed, and the prevalence rate (53%) was significantly higher than that of other subtypes, and the probability of bilateral lesions was higher (40%). The sonogram often showed ultrasound features of papillary neoplasm in the lesion and good internal echo (p<0.05). Mucinous borderline ovarian tumors (MBOTs) were mostly unilateral lesions (86%). The prevalence was second only to SBOTs. Histomorphological examinations were divided into gastrointestinal-type and endocervical-type. Among them, the gastrointestinal type of MBOTs were mostly unilateral, and their incidence was higher than that of endocervical-type of MBOTs. Compared with other pathological subtypes, the gastrointestinal type is more likely to show the sonographic characteristics of huge space occupying in the pelvic and abdominal cavity (mean diameter >10 cm), polycystic, multiple septums, and poor internal echo (p<0.05). The ultrasonographic features of the endocervical-type of MBOTs were similar to those of SBOTs. Compared with gastrointestinal type, the sonographic images showed smaller lesion diameter, less septal or cyst, and more papillary excrescences in the tumor (p<0.05). The borderline clear cell tumor is the intermediate transition between the clear cell adenofibroma and the clear cell carcinoma. The clinical manifestations are diverse and lack specificity. The histology of sonography was mainly solid, and the multiple microcapsules were honeycomb-like. It can also be shown as cystic. Among the 169 patients with BOTs, 20 cases of SBOTs, 17 cases of MBOTs, and 10 cases of other rare subtypes were complicated with other diseases or multiple subtypes. This study did not find significant ultrasonic characteristics were used for distinguish them from other subtypes.
Conclusion: BOTs is a common disease in women during the reproductive period. It is characterized by the development of malignant tumors. Its clinical and pathological subtypes are complex and diverse. It leads many doctors to use the terms “large pelvic mass” and “solid ovarian mass” for diagnosis because of their lack of experience and understanding.
Keywords: adenocarcinoma, mucinous; adenocarcinoma, serous; borderline ovarian tumors; diagnostic imaging; ovarian neoplasms; papillary neoplasms; prognosis; transvaginal ultrasound, ultrasonography
Tubular Adenoma of the Breast: A Rare Case Presentation and Review of Literat...Crimsonpublisherssmoaj
Tubular Adenoma of the Breast: A Rare Case Presentation and Review of Literature by Emmanuel Owusu Ofori* in Crimson Publishers: Surgery Open Access Journal
Tubular adenomas are a rare breast entity constituting 0.3-1.7% of all benign tumours first described in 1968 typically affecting women in their reproductive ages (15-49 years). Few cases have been reported in the literature. They are rarely found before menarche or after menopause. Preoperatively, tubular adenomas are difficult to differentiate from fibroadenoma, phyllodes and tubular carcinoma. We report the case of a 25-year-old female who reported to our clinic with 4-month history of painless left breast mass which had not seen any significant changes in size. Histological findings were consistent with tubular adenoma.
https://crimsonpublishers.com/smoaj/fulltext/SMOAJ.000541.php
For more open access journals in Crimson Publishers
Please click on: https://crimsonpublishers.com/
For more articles on Surgery Open Access Journal
Please click on link: https://crimsonpublishers.com/smoaj/index.php
Please follow the below link for our LinkedIn page
https://www.linkedin.com/company/crimsonpublishers
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
An exophytic lesion of the vagina cytological findings
1. EDUCATIONAL CASE REPORT
An exophytic lesion of the vagina – cytological findings
M. Pajtler*, M. Milojkovic´
and M. Mrcˇelaà
*Department of Clinical Cytology, Department of Gynecology and àDepartment of Pathology,
University Hospital ÔOsijekÕ, Osijek, Croatia
Accepted for publication 11 March 2003
Introduction
Primary melanoma of the vagina is rare, with less
than 250 reported cases to date.1
This tumour
constitutes less than 3% of all vaginal malignancies1,2
and less than 1% of all melanomas in women.3,4
The
majority of patients in the literature are isolated case
reports.5–7
By comparison, 93% of melanomas are
cutaneous, 5.2% are ocular, and 0.4% are oronasal.8
Its clinical behaviour in the vagina is notoriously
more aggressive than that of cutaneous and vulvar
melanoma, with 5-year survival rate ranging from
13% to 19%.3,4
The most appropriate treatment for vaginal melan-
oma has been the subject of some debate. Some
authors9,10
have found no difference in overall 5-year
survival between conservative surgery, radical sur-
gery, radiation, or chemotherapy. Others 11–13
have
recently argued at least better 2-year survival with
radical surgery (total colpectomy or pelvic exentera-
tion). These and other studies have been hampered by
too few cases over many years, precluding any
prospective controlled trials.
These tumours appear to originate from melano-
cytes that are present in the vaginal mucosa of
approximately 3% of women.14,15
They occur more
commonly in the lower third of the vagina,9,16
more
often on the anterior surface, and commonly produce
symptoms of bleeding (79%) or discharge (24%).16
Diagnosis has been made in the absence of symptoms
in only a few patients.
Case of primary malignant melanoma of the vagina
with special reference to the cytological findings has
been presented.
Case report
A 74-year-old woman who sought gynaecological
help due to prolapse of the anterior vaginal wall has
been presented. Gynaecological examination detected
a lesion consisting of few pink pale exophytic nodules
0.5 cm in diameter, among which black-pigmented
areas at mucosa level could be seen. A direct smear
was taken and stained by the Papanicolaou method.
The cytological smear had a clean background and
showed, in addition to the predominantly interme-
diate squamous cells, numerous malignant cells,
either isolated or in small sheets. The cells had
polygonal, oval, fusiform or irregular shapes, with
marked anisocytosis. The cytoplasm was wispy and
cyanophilic, relatively clear with indistinct borders.
The nuclei were very large and located centrally,
although some were eccentric. They were oval,
elongated or lobulated in shape, with a moderately
granular, uneven chromatin pattern, prominent nuc-
lear membranes and prominent nucleoli. Giant multi-
nucleated cells were also found (Figure 1–2). The
cytological diagnosis was squamous cell carcinoma.
The patient had a colposcopically guided biopsy of the
vaginal lesion which showed tumour tissue consisting
of clusters of atypical oval, rounded and polygonal
cells, many of which contained brown pigment
granules of melanin. The nuclei were large, round to
oval, with prominent nucleoli and abnormal mitoses.
The surface consisted of patchily thinned squamous
epithelium, infiltrated with tumour tissue. The histo-
logical findings were those of a malignant melanoma
(Figure 4). Owing to the site of the tumour and the
patient’s age, no oncological therapy was undertaken
and the patient did not come for any follow-up.
Discussion
The smear from the polypoid vaginal lesion identi-
fied malignant cells, which differed from the
Correspondence:
Marija Pajtler, MD, Department of Clinical Cytology, Clinical
Hospital Osijek, 31000 Osijek, J. Huttlera 4, Croatia.
Tel.: 031-511 510;
E-mail: pajtler.marija@kbo.hr
Cytopathology 2003, 14, 150–152 ª 2003 Blackwell Publishing Ltd150
2. common cytological findings in Papanicolaou-stained
cervicovaginal smears.
They were misdiagnosed for several reasons, the
first being lack of experience, as primary malignant
melanoma of vagina occurs very rarely, and the
cytological findings have been described only infre-
quently.17–22
Secondly, most of the malignant cells
did not contain pigment to indicate the tumour type.
On review after the histological diagnosis, brown-
green pigment granules were noted in the cytoplasm
of only one cluster of malignant cell, as well as in one
benign squamous cell, difficult to detect under low
power magnification (Figure 3). This finding,
together with the clinical description perfectly
matched the histology, in which most of the malig-
nant cells were without pigment (Figure 4). The
differential diagnosis was thought to include adeno-
carcinoma because of the nuclear characteristics and
prominent nucleoli, but the distribution of cells and
absence of three-dimensional structures suggested
otherwise. In spite of being atypical, the findings
matched the description of poorly differentiated
squamous carcinoma. Identical cytomorphological
characteristics from other locations, especially in
smears stained by May–Grunwald–Giemsa would be
suspected of malignant melanoma, even without
pigment. However, the gynaecologist failed to men-
tion the prominent black-pigmented areas within the
lesion, which might have helped to diagnose the
exact type of malignant lesion.
Figure 1. Vaginal smear (Papanicolaou, ·400). Figure 2. Vaginal smear (Papanicolaou, ·1000).
Figure 3. Vaginal smear (Papanicolaou, ·1000). Figure 4. Histology of the lesion (H&E, ·400).
Exophytic lesion of the vagina 151
Cytopathology 2003, 14, 150–152 ª 2003 Blackwell Publishing Ltd
3. In order to accurately diagnose cytologically in the
case of rare lesions, the gynaecologist should describe
the clinical findings fully, and the cytologist should
analyse all morphological details thoroughly, bearing
in mind the question ÔWhat other diagnosis might also
be considered?Õ
References
1 Piura B, Rabinovich A, Yanai-Inbar I. Primary malignant
melanoma of the vagina: case report and review of
literature. Eur J Gynaecol Oncol 2002; 23: 195–8.
2 Chung AF, Casey MJ, Flannery JT, Worded JM, Lewis JL,
Jr. Malignant melanoma of the vagina – report of 19
cases. Obstet Gynecol 1980; 55: 720–7.
3 Weinstock MA. Malignant melanoma of the vulva and
vagina in the United States: patterns of incidence and
population-based estimates of survival. Am J Obstet Gynecol
1994; 171: 1225–30.
4 Ragnarsson-Olding B, Johansson H, Rutquist LE, Ring-
borg U. Malignant melanoma of the vulva and vagina.
Cancer 1993; 71: 1893–7.
5 Buchanan DJ, Schlaerth J, Kurosaki T. Primary vaginal
melanoma: thirteen-year disease-free survival after wide
local excision and review of recent literature. Am J Obstet
Gynecol 1998; 178: 1174–84.
6 Borazjani G, Prem KA, Okagaki T, Twiggs LB, Adcock LL.
Primary malignant melanoma of the vagina: a clinico-
pathological analysis of 10 cases. Gynecol Oncol 1990; 37:
264–7.
7 Kimura C, Furuya K. A case of pedunculated malignant
melanoma of the vaginal mucosa. J Dermatol 2001; 28:
564–8.
8 Chiu N, Weinstock MA. Melanoma of oronasal mucosa:
population based analysis of occurrence and mortality.
Arch Otolaryngol Head Neck Surg 1996; 122: 985–8.
9 Morrow CP, DiSaia PJ. Malignant melanoma of the
female genitalia: a clinical analysis. Obstet Gynecol Surv
1976; 31: 233–71.
10 Levitan Z, Gordon AN, Kaplan AL, Kaufman RH. Primary
malignant melanoma of the vagina: report of four cases
and review of the literature. Gynecol Oncol 1989; 33: 85–
90.
11 Van Nortstrand KM, Lucci JA, Schell M, Berman ML,
Manetta A, DiSaia PJ. Primary vaginal melanoma:
improved survival with radical pelvic surgery. Gynecol
Oncol 1994; 55: 234–7.
12 Geisler JP, Look KY, Moore DA, Sutton GP. Pelvic
exeneteration for malignant melanoma of the vagina or
urethra with over 3mm of invasion. Gynecol Oncol 1995;
59: 338–41.
13 Brand E, Fu YS, Lagasse LD, Berek JS. Vulvovaginal
melanoma: report of seven cases and literature review.
Gynecol Oncol 1989; 33: 54–60.
14 Nigogosyan G, DeLaPava S, Pickren JW. Melanoblasts in
vaginal mucosa. Cancer 1964; 17: 1912–3.
15 Lotem M, Anteby S, Peretz T, Ingber A, Avinoach I, Prus
D. Mucosal melanoma of the female genital tract is a
multifocal disorder. Gynecol Oncol 2003; 88: 45–50.
16 Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barret
RJ, Morley GW. Primary melanoma of the vagina: a
clinicopathological analysis. Obstet Gynecol 1989; 74:
190–9.
17 Ehrmann RL, Younge PA, Lerch VL. The exfoliative
cytology and histogenesis of an early primary malignant
melanoma of the vagina. Acta Cytol 1962; 6: 245–54.
18 Aschitaka Y, Taki I, Yanagida T. The cytologic findings of
malignant melanoma of the vaginal wall. J Jap Soc Clin
Cytol 1963; 4: 27.
19 Masubuchi K, Fujii J, Jyuzoji S, Kimura M, Yamazaki M.
Cytologic studies in malignant melanoma of the vagina.
J Jap Soc Clin Cytol 1969; 8: 66–9.
20 Masubuchi S, Jr, Nagai I, Hirata M, Kubo H, Masubuchi
K. Cytologic studies of malignant melanoma of the
vagina. Acta Cytol 1975; 19: 527–32.
21 Sagebiel RW, Gates EA, Hill LC. Cytologic detection of
recurrent vaginal melanoma. Acta Cytol 1978; 22: 353–7.
22 Genton CY, Kunz J, Schreiner WE. Primary malignant
melanoma of the vagina and cervix uteri. Report of a case
with ultrastructural study. Wirchows Arch (Pathol Anat)
1981; 393: 245–50.
M. Pajtler et al.152
Cytopathology 2003, 14, 150–152 ª 2003 Blackwell Publishing Ltd